Gut microbiota, comprising trillions of microorganisms, plays a pivotal role in human health, influencing everything from digestion to immune function. Disruptions in this delicate ecosystem are linked to various diseases, including inflammatory bowel diseases, obesity, and even mental health disorders. Probiotics, live beneficial bacteria, and prebiotics, non-digestible fibers that fuel the growth of these bacteria, offer promising avenues for intervention.
Probiotics introduce beneficial strains to bolster gut health, potentially alleviating symptoms of gastrointestinal disorders. Prebiotics, on the other hand, nourish existing beneficial bacteria, promoting their proliferation. Together, they form a symbiotic relationship, optimizing the gut environment. While research continues to unravel the intricacies of gut microbiota, harnessing the potential of probiotics and prebiotics offers novel therapeutic strategies to combat various diseases and promote overall well-being.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India